Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)

<p>Abstract</p> <p>Background</p> <p>Intravesical Bacillus Calmette-Guerin (BCG) is an effective treatment for bladder superficial carcinoma and it is being tested in interstitial cystitis patients, but its precise mechanism of action remains poorly understood. It is no...

Full description

Bibliographic Details
Main Authors:	Centola Michael, Frank Mark, Knowlton Nicholas, Wallis Gemma, Davis Carole, Simpson Cindy, Saban Marcia R, Gallucci Randle M, Saban Ricardo
Format:	Article
Language:	English
Published:	BMC 2007-05-01
Series:	BMC Immunology
Online Access:	http://www.biomedcentral.com/1471-2172/8/6

Similar Items

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024-12-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
by: Masashi Miyazaki, et al.
Published: (2016-01-01)

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
by: Akihito Kawai, et al.
Published: (2022-11-01)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
by: Bedeir Ali-El-Dein, et al.
Published: (2013-01-01)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
by: Cindy Garcia, et al.
Published: (2016-01-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Systemic bacillus Calmette-Guérin (BCG) infection and accompanying warm autoimmune haemolytic anaemia following intravesical BCG immunotherapy
by: Alper Tuna Güven, et al.
Published: (2023-08-01)

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
by: Eric Gomez, et al.
Published: (2009-01-01)

Granulomatous Prostatitis Associated with Intravesical Bacillus Calmette Guerin Therapy
by: Elif Gündoğdu
Published: (2024-02-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: Case report
by: Hajar Aown Allah Alsulami, et al.
Published: (2023-01-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
by: Sayed Ab. Reshad Ghafouri, et al.
Published: (2018-01-01)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)
by: Yuvaraja B. Thyavihally, et al.
Published: (2022-04-01)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
by: Fumie Yoshioka, et al.
Published: (2023-03-01)

Is bladder tumor location associated with prostate cancer detection after intravesical bacillus Calmette-Guérin instillation?
by: Sungwoo Hong, et al.
Published: (2014-01-01)

Bacillus Calmette–Guerin intravesical instillation therapy-induced urothelial necrosis of the bladder and upper urinary tract
by: Tsubasa Kondo, et al.
Published: (2022-09-01)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01)

The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
by: Jong Ho Park, et al.
Published: (2024-11-01)

Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
by: Ofer N Gofrit, et al.
Published: (2019-01-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

Is intravesical bacillus Calmette-Guerin safe and efficacious in steroid treated and immunocompromized patients
by: Santosh Kumar, et al.
Published: (2006-01-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Successful treatment with low‐dose oral steroids for contracted bladder after intravesical instillation of Bacillus Calmette–Guérin
by: Akinobu Katami, et al.
Published: (2024-03-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)

Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature
by: Konstantinos Manganas, et al.
Published: (2022-10-01)

Bacillus Calmette-Guerin in the management of superficial bladder cancer
by: Rakesh Kapoor, et al.
Published: (2008-01-01)

Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia
by: Chamodi Pillippu Hewa, et al.
Published: (2024-02-01)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report
by: Hiroshi Shimura, et al.
Published: (2017-02-01)

A case of generalized granuloma annulare induced by intravesical bacillus calmette–Guerin immunotherapy
by: Joohyung Youh, et al.
Published: (2023-01-01)

Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy
by: Jeong Ho Eom, et al.
Published: (2016-09-01)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
by: Chae Hun Lee, et al.
Published: (2023-10-01)

A case of renal granulomatosis with polyangiitis following intravesical bacillus Calmette-Guérin therapy
by: Yosra Selmi, et al.
Published: (2018-01-01)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
by: Frédéric Quatannens, et al.
Published: (2022-07-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
by: Antoine John, et al.
Published: (2011-09-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
by: Andreas Bohle
Published: (2011-04-01)